Comprehensive Study Notes on Type 2 Diabetes, Lactose Intolerance, and Blood Cholesterol Management

Carbohydrate Digestion, Absorption, and Glucose Metabolism

• Carbohydrate Digestibility and Classification:

  • Monosaccharides: Readily digestible single-sugar units (e.g., glucose, fructose, galactose).
  • Disaccharides: Readily digestible double-sugar units (e.g., sucrose from table sugar).
  • Digestible Polysaccharides: Complex carbohydrates that are enzymatic broken down and absorbed (e.g., starch from bread).
  • Non-digestible Oligosaccharides and Polysaccharides (Dietary Fibre):
  • Soluble Fibre: Dissolves in water to form a gel structure and is fermentable by gut bacteria (e.g., fibre found in oats and barley).
  • Insoluble Fibre: Does not dissolve in water and is non-fermentable (e.g., fibre found in lettuce and various vegetables).

• Physiological Regulation of Blood Glucose Abundance:

  • Normal blood glucose concentration is tightly regulated within a physiological homeostatic range of $70\,\text{mg/dl}$ to $100\,\text{mg/dl}$.
  • Elevated blood glucose levels signal the $\beta$-cells located in the islets of Langerhans within the pancreas to release the hormone insulin into circulation.
  • Insulin binds to its specific surface receptor on peripheral body cells, promoting cellular glucose uptake from the bloodstream.
  • Intracellular metabolic pathways for absorbed glucose:
  • Glycolysis: The initial step and fundamental metabolic pathway for cellular energy production.
  • Glycogenesis: The conversion of excess glucose into stored glycogen for energy reserves.
  • Lipogenesis: Synthesis and storage of lipids derived from excess glucose.
  • Response to falling blood glucose:
  • Low blood glucose concentration triggers the pancreas to release the hormone glucagon.
  • Glucagon stimulates increased gluconeogenesis (synthesis of new glucose) and glycogen breakdown to normalize blood glucose levels.

Type 2 Diabetes Mellitus

• Pathophysiology and Progression:

  • Type 2 diabetes is a chronic metabolic condition characterized by hyperglycaemia (prolonged elevated blood glucose levels).
  • Body cells develop resistance to the biological action of insulin, preventing efficient uptake of circulating glucose.
  • Compensatory Hyperinsulinemia: The pancreas increases insulin secretion to compensate for cellular resistance.
  • Pancreatic Exhaustion: Over time, the pancreas becomes exhausted, leading to a progressive decline in insulin production.
  • Sustained Hyperglycaemia: As insulin output drops while cellular resistance persists, blood glucose levels continuously rise.

• Distinctions Between Diabetes Types:

  • Type 1 Diabetes Mellitus:
  • Caused by insufficient insulin production by the pancreas, primarily due to autoimmune destruction of pancreatic $\beta$-cells.
  • Commonly diagnosed during childhood or adolescence and requires lifelong management.
  • Type 2 Diabetes Mellitus:
  • Initiated by insulin resistance in target cells, followed by a decline in pancreatic insulin secretion.
  • Central adiposity (visceral body fat accumulation) is a major contributor to insulin resistance.
  • Predominantly diagnosed in adulthood.
  • Gestational Diabetes:
  • Glucose intolerance that develops specifically during pregnancy.
  • Typically resolves spontaneously following delivery.

• Clinical Symptoms and Diagnostic Markers:

  • Individuals are frequently asymptomatic until late stages of disease progression.
  • Diagnosis must be clinically confirmed through laboratory blood tests evaluating glucose and insulin parameters.
  • Characteristic clinical symptoms:
  • Polyuria (increased frequency and volume of urination).
  • Increased thirst (polydipsia) and excessive hunger (polyphagia).
  • Unexplained weight loss or weight gain.
  • Recurrent headaches and dizziness.
  • Impaired or slow wound healing and heightened susceptibility to infections.
  • Darkening of the skin (acanthosis nigricans).

• Ketone Metabolism and Severe Complications:

  • Ketone Body Biochemistry:
  • When intracellular carbohydrate availability is deficient, body tissues catabolize fatty acids for energy.
  • In the absence of sufficient carbohydrates, fatty acid breakdown yields an accumulation of ketone bodies.
  • Key chemical structures involved include acetoacetate (an acidic ketone body, $\text{C}_4\text{H}_6\text{O}_3$) and acetone ($\text{C}_3\text{H}_6\text{O}$).
  • Ketosis and Acid-Base Balance:
  • Because several ketone bodies are organic acids, their excessive buildup disrupts systemic acid-base balance, inducing ketosis.
  • Ketosis is particularly common in undiagnosed or poorly managed diabetes.
  • Clinical Complications:
  • Diabetic Ketoacidosis (DKA): Clinical syndrome manifested by acetone breath (fruity odor), ketonemia (elevated ketones in blood), ketonuria (ketones present in urine), weight loss, polyphagia, and risk of fatal diabetic coma.
  • Hyperosmolar Hyperglycemic State (HHS): Severe metabolic emergency that usually develops in the absence of significant ketosis and is most commonly associated with Type 2 diabetes.

Lactose Intolerance and Malabsorption

• Lactose Digestion Mechanics:

  • Lactose is a disaccharide carbohydrate found in dairy products.
  • Normal lactose digestion depends on the functional enzyme lactase, which is located in the microvilli of the small intestine.
  • Lactase enzymatically hydrolyzes lactose into its component monosaccharides: glucose and galactose.
  • Intestinal Absorption: Free glucose and galactose are transported across the brush-border membrane into enterocytes via Sodium/Glucose Cotransporter-1 ($\text{SGLT1}$).

• Etiology and Pathophysiology of Lactase Deficiency:

  • Lactose intolerance stems from incomplete lactose digestion caused by a deficiency in functional lactase.
  • Primary and Secondary Etiologies:
  • Age-Related Decline: Natural decrease in lactase enzyme expression produced in the small intestine over time.
  • Congenital Deficiency: Rare genetic defect present from birth resulting in little to no lactase enzyme production.
  • Secondary Mucosal Damage: Loss of intestinal microvilli secondary to gastrointestinal diseases (e.g., Crohn's disease, Coeliac disease), surgical procedures damaging intestinal mucosa, or therapies such as radiation.
  • Intestinal Cascade during Malabsorption:
  • Undigested lactose passes unchanged into the large intestine (colon).
  • Osmotic Draw: Unabsorbed lactose creates an osmotic gradient that draws water ($\text{H}_2\text{O}$) into the colonic lumen, causing watery osmotic diarrhea.
  • Microbial Fermentation: Microbes in the colon rapidly ferment undigested lactose, producing short-chain fatty acids ($\text{SCFAs}$) and gases including carbon dioxide ($\text{CO}_2$) and hydrogen ($\text{H}_2$).
  • Clinical Symptoms: While some $\text{SCFAs}$ are absorbed for minimal energy salvage, gas formation ($\text{CO}_2 + \text{H}_2$) causes gut wall distension, flatulence, abdominal bloating, hypermotility/increased peristalsis, and severe gastrointestinal pain.

• Prevalence and Clinical Management:

  • Demographic Patterns: Elevated prevalence is observed in Indigenous, Asian, and African American populations due to a strong genetic component associated with lactase non-persistence.
  • Dietary Thresholds:
  • Most individuals with lactose intolerance can comfortably digest small amounts of dairy.
  • The typical daily tolerance threshold ranges between $6\,\text{g/day}$ and $12\,\text{g/day}$ of lactose.
  • Tolerance is optimized when lactose intake is divided into small portions consumed throughout the day.
  • Dietary management focused on controlled intake is preferred over complete exclusion of dairy.
  • Dietary Lactose Profiles:
  • High-Lactose Foods: Milk (all fat percentages), high-milk content foods (e.g., white chocolate, milk chocolate), yogurts, ice cream, fresh cream, and soft cheeses.
  • Low-Lactose Foods: Hard cheeses naturally contain minimal to negligible lactose levels.
  • Database Reference: Dietary lactose content can be referenced in the Australian Food Composition Database.
  • Management Options:
  • Commercially available lactose-free dairy alternatives (e.g., Liddells lactose-free reduced fat milk, lactose-free ice cream).
  • Plant-based dairy-free milks (e.g., soy, almond, oat milks).
  • Exogenous lactase enzyme supplements (available over the counter at pharmacies).

Blood Cholesterol Levels and Cardiovascular Health

• Endogenous Cholesterol Synthesis and Functions:

  • Physiological Roles: Essential structural constituent of cellular membranes and an obligate biochemical precursor for steroid hormones and bile acids.
  • Synthesis Sites: Endogenously produced throughout the body, with highest synthesis rates occurring in the liver, small intestine, adrenal cortex, and gonads.
  • Clinical Pathology: Elevated blood cholesterol—specifically elevated Low-Density Lipoprotein ($\text{LDL}$) cholesterol—substantially elevates the risk of Cardiovascular Disease ($\text{CVD}$).

• Structural Classes of Circulating Lipoproteins:

  • Lipoprotein Architecture: Spherical complexes featuring a hydrophobic inner core (triglycerides and cholesterol esters) surrounded by an amphipathic monolayer of phospholipids and apolipoproteins. Phospholipid fatty acid tails orient toward the core, while hydrophilic outer groups face the aqueous blood matrix.
  • Lipoprotein Spectrum (ordered by density, size, and compositional ratio):
  • Chylomicrons: Largest in diameter and lowest in density; composed predominantly of dietary triglycerides with minimal protein content.
  • Very-Low-Density Lipoproteins ($\text{VLDL}$): Composed of approximately $50\%$ triglycerides; possess very low density.
  • Low-Density Lipoproteins ($\text{LDL}$): Composed of approximately $50\%$ cholesterol; accounts for approximately $70\%$ of total circulating blood cholesterol. Termed "bad" cholesterol because high systemic levels promote arterial fatty deposits and luminal blockages.
  • High-Density Lipoproteins ($\text{HDL}$): Highest density and smallest particle size; composed of approximately $50\%$ protein; accounts for approximately $20\%$ of total blood cholesterol. Termed "good" cholesterol because it extracts excess cholesterol from arterial tissues and transports it back to the liver for metabolic processing.

• Coronary Artery Disease and Atherosclerosis:

  • Pathogenesis: Injury or inflammation of the arterial endothelium enables cholesterol-containing plaque to deposit inside the lining of coronary arteries.
  • Plaque Progression: Sustained plaque growth impairs vascular lumen dimensions and arterial elasticity.
  • Thrombus Formation: Ruptured arterial plaque stimulates rapid platelet activation and blood clot formation, potentially occluding coronary arterial flow and inducing a myocardial infarction (heart attack).

• Blood Lipid Reference Ranges and Diagnostic Equation:

  • Total Cholesterol Formula:     $\text{Total Cholesterol} = \text{HDL} + \text{LDL} + 0.20 \times \text{Triglycerides}$
  • Standard Diagnostic Reference Thresholds:
  • High-Density Lipoprotein ($\text{HDL}$) Cholesterol: Desirable level is $> 1.0\,\text{mmol/L}$ (higher concentrations reduce cardiovascular risk).
  • Low-Density Lipoprotein ($\text{LDL}$) Cholesterol:
    • Desirable range: $< 2.5\,\text{mmol/L}$
    • Borderline elevated range: $2.5\,\text{mmol/L}$ to $4.5\,\text{mmol/L}$
    • High risk threshold: $> 4.5\,\text{mmol/L}$
  • Serum Triglycerides:
    • Desirable range: $< 1.7\,\text{mmol/L}$
    • Borderline elevated range: $1.7\,\text{mmol/L}$ to $2.5\,\text{mmol/L}$
    • High risk threshold: $> 2.5\,\text{mmol/L}$

• Dietary Strategies and Mechanisms for Lipid Management:

  • Primary Dietary Risk Factors:
  • High Saturated Fat Intake: Serves as the primary dietary cause of elevated circulating $\text{LDL}$ cholesterol and depressed $\text{HDL}$ cholesterol.
  • Excess Total Energy Intake: Excess caloric intake promotes hyperlipidemia and lipid accumulation.
  • Cardioprotective Dietary Modifications:
  • Transitioning to low-fat dairy options and lean cuts of meat.
  • Increasing intake of foods abundant in dietary fibre and unsaturated healthy fats (e.g., nuts, seeds, legumes).
  • Regular consumption of fish, fruits, vegetables, and whole grains.
  • Specific Lipid-Lowering Biochemical Mechanisms:
  • Soluble Beta-Glucans:
    • A soluble dietary fibre prevalent in oats and legumes.
    • Beta-glucan polymers bind bile acids inside the intestinal tract, promoting their fecal excretion.
    • Reduced enterohepatic bile reabsorption forces the liver to clear circulating cholesterol to synthesize replacement bile acids, driving down systemic blood cholesterol levels.
  • Plant Sterols (Phytosterols):
    • Naturally occurring plant compounds (e.g., campesterol, $\beta$-sitosterol, $\beta$-sitostanol) present in small amounts in fruits/vegetables or added to fortified margarines and yogurts.
    • Possess chemical structures closely resembling cholesterol, allowing them to competitively block intestinal cholesterol absorption and reduce overall uptake into circulation.
  • Microbial Fermentation of Dietary Fibre:
    • Fermentation of dietary fibre by beneficial gut microbes produces bioactive metabolic by-products ($\text{SCFAs}$).
    • These bacterial by-products increase bile excretion and downregulate key endogenous enzymes controlling liver cholesterol synthesis.
    • Evidence supports a dose-dependent reduction in total and $\text{LDL}$ cholesterol relative to dietary fibre intake; clinical guidelines recommend consuming a combination of both soluble and insoluble fibre.